Back to News Page
Source: Bitget
As the global cost of Alzheimer’s care accelerates toward $14.5 trillion by 2050, AI-powered solutions like Lizzy Care are emerging as essential tools to reduce healthcare strain, expand access, and support families through scalable at-home dementia care.
Source: Startup Health
SynchNeuro has secured seed-stage support from Boomerang Ventures to advance its brain-based, non-invasive continuous glucose monitoring technology. Using EEG-derived signals decoded by machine learning, the company is developing a wearable “Cardiometabolic Advisor” that tracks blood glucose and metabolic indicators without needles. The investment accelerates development and moves the device closer to broad market adoption.
Source: CityBiz
SynchNeuro, a Philadelphia-based health-technology startup founded by neurosurgeon Dr. Casey Halpern, has secured seed funding from Boomerang Ventures. The company is developing a non-invasive EEG-based platform that decodes brain-signal activity into metabolic insights, aiming to support individuals with prediabetes and early-stage Type 2 diabetes. The investment will help expand operations and accelerate product development.
Source: Digital Health News
Mentavi Health has launched Mentavi Concierge, an AI-powered mental health platform designed to elevate standards of safety, transparency, and clinical oversight in digital care. The system combines advanced conversational AI with licensed clinicians, embedded safety protocols, mood tracking, and human-in-the-loop review to ensure ethical, personalized, and HIPAA-compliant support. CEO Keith Brophy emphasizes that the technology is “patient-lifting, not job-replacing,” reinforcing Mentavi’s commitment to responsible innovation in mental healthcare.
Source: Indianapolis Business Journal
Boomerang Ventures has taken the lead in a $3 million seed round for SynchNeuro Inc., a Philadelphia-based health tech startup developing a wearable sensor that translates brainwave activity into real-time health insights. As part of the investment, Boomerang Founder and Managing Partner Oscar Moralez has joined the company’s board, strengthening the partnership as SynchNeuro advances its technology to monitor blood sugar and other critical health metrics.
Source: Tech Point
Boomerang Ventures is backing SynchNeuro’s pioneering effort to build the world’s first brain-based, non-invasive continuous glucose monitor. Using EEG-derived brainwave signals decoded by machine learning, SynchNeuro aims to track blood glucose and cardiometabolic indicators via a discreet wearable placed behind the ear. This seed-stage investment will help speed development of the “Cardiometabolic Advisor” system and bring proactive, needle-free monitoring closer to mass market.
Source: Business Insider
Boomerang Ventures has announced a seed-stage investment in SynchNeuro, a Philadelphia-based startup developing a brain-based, non-invasive wearable sensor to monitor blood glucose and other vital health metrics in real time. The firm’s backing supports SynchNeuro’s mission to use EEG-derived data and machine learning for proactive, needle-free cardiometabolic health insights.
Source: Morningstar
Boomerang Ventures has added SynchNeuro, Inc. to its seed-stage portfolio, investing to accelerate development of the world’s first brain-based, non-invasive continuous glucose monitor. The Indianapolis-based fund is backing the startup’s EEG-driven platform that decodes brainwave signals behind the ear to monitor glucose, sleep, stress and cardiometabolic health in real time. “The brain is the richest data source imaginable,” says SynchNeuro founder Dr. Casey Halpern.
Boomerang Ventures has announced a seed-stage investment in SynchNeuro, a pioneering neurotechnology company developing the world’s first brain-based, non-invasive continuous glucose monitor. The partnership accelerates SynchNeuro’s mission to revolutionize cardiometabolic health through EEG-based technology that interprets brain signals to track blood glucose and other vital metrics in real time. This innovative approach aims to make proactive, pain-free, and affordable glucose monitoring accessible to millions.
Source: Indianapolis Business Journal
Artificial intelligence is reshaping the startup landscape by drastically cutting costs and reducing the need for large teams or early venture funding. Investors such as Boomerang Ventures’ Tejas Vijh are seeing early-stage companies raise smaller rounds, build faster, and operate leaner as AI transforms both startup creation and venture capital strategy.
Back to News Page
